Abnormal bone and mineral metabolism in kidney transplant patients - A review

被引:60
作者
Sprague, Stuart M.
Belozeroff, Vasily
Danese, Mark D.
Martin, Lynn P.
Olgaard, Klaus
机构
[1] Northwestern Univ, Feinberg Sch Med, Evaston Northwestern Hlthcare, Evanston, IL USA
[2] Amgen Inc, Thousand Oaks, CA USA
[3] Outcome Insights Inc, Newbury Pk, CA USA
[4] Univ Copenhagen, Rigshosp, Dept Nephrol, Copenhagen, Denmark
关键词
kidney transplant; hyperparathyroidism; secondary; mineral metabolism; bone disease; post-transplant;
D O I
10.1159/000110875
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
Background/Aims: Abnormal bone and mineral metabolism is common in patients with kidney failure and often persists after successful kidney transplant. Methods: To better understand the natural history of this disease in transplant patients, we reviewed the literature by searching MEDLINE for English language articles published between January 1990 and October 2006 that contained Medical Subject Headings and key words related to secondary or persistent hyperparathyroidism and kidney transplant. Results: Parathyroid hormone levels decreased significantly during the first 3 months after transplant but typically stabilized at elevated values after 1 year. Calcium tended to increase after transplant and then stabilize at the higher end of the normal range within 2 months. Phosphorus decreased rapidly to within or below normal levels after surgery and hypophosphatemia, if present, resolved within 2 months. Low levels of 1,25(OH) 2 vitamin D typically did not reach normal values until almost 18 months after transplant. Conclusion: This review provides evidence demonstrating that abnormal bone and mineral metabolism exists in patients after kidney transplant and suggests the need for treatment of this condition. However, better observational and interventional research is needed before advocating such a treatment guideline.
引用
收藏
页码:246 / 253
页数:8
相关论文
共 59 条
[1]   Bone mineral recovery after parathyroidectomy in patients with primary and renal hyperparathyroidism [J].
Abdelhadi, M ;
Nordenstrom, J .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1998, 83 (11) :3845-3851
[2]   Relationship of posttransplantation erythrocytosis to hypercalcemia in renal transplant recipients [J].
Akcay, A ;
Kanbay, M ;
Huddam, B ;
Usluogullari, CA ;
Arat, Z ;
Ozdemir, FN ;
Haberal, M .
TRANSPLANTATION PROCEEDINGS, 2005, 37 (07) :3103-3105
[3]   Changes in bone mineral density and selected metabolic parameters over 24 months following renal transplantation [J].
Al-Gabri, S ;
Zadrazil, J ;
Krejci, K ;
Horák, P ;
Bachleda, P .
TRANSPLANTATION PROCEEDINGS, 2005, 37 (02) :1014-1019
[4]   LOSS OF REGIONAL BONE-MINERAL DENSITY IN THE 1ST 12 MONTHS FOLLOWING RENAL-TRANSPLANTATION [J].
ALMOND, MK ;
KWAN, JTC ;
EVANS, K ;
CUNNINGHAM, J .
NEPHRON, 1994, 66 (01) :52-57
[5]  
[Anonymous], COCHRANE DATABASE SY
[6]  
BAGNI B, 1994, EUR J NUCL MED, V21, P108
[7]   Changes in serum osteocalcin levels in the follow-up of kidney transplantation [J].
Bonnin, MR ;
Gonzalez, MT ;
Grino, JM ;
Cruzado, JM ;
Bover, J ;
Martinez, JM ;
Navarro, MA .
ANNALS OF CLINICAL BIOCHEMISTRY, 1997, 34 :651-655
[8]   Lumbar bone mineral density in very long-term renal transplant recipients: Impact of circulating sex hormones [J].
Brandenburg, VM ;
Ketteler, M ;
Heussen, N ;
Politt, D ;
Frank, RD ;
Westenfeld, R ;
Ittel, TH ;
Floege, J .
OSTEOPOROSIS INTERNATIONAL, 2005, 16 (12) :1611-1620
[9]   Development of lumbar bone mineral density in the late course after kidney transplantation [J].
Brandenburg, VM ;
Ketteler, M ;
Fassbender, WJ ;
Heussen, N ;
Freuding, T ;
Floege, J ;
Ittel, TH .
AMERICAN JOURNAL OF KIDNEY DISEASES, 2002, 40 (05) :1066-1074
[10]   Changes in bone mineral density over 18 months following kidney transplantation: the respective roles of prednisone and parathyroid hormone [J].
Casez, JP ;
Lippurer, K ;
Horber, FF ;
Montandon, A ;
Jaeger, P .
NEPHROLOGY DIALYSIS TRANSPLANTATION, 2002, 17 (07) :1318-1326